• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    7.460 -12.240 (-62.13%)
    Streaming Delayed Price Updated: 12:33 PM EDT, Jul 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 18,129,440
    Open 5.860
    Bid (Size) 7.440 (2,900)
    Ask (Size) 7.460 (2,000)
    Prev. Close 19.70
    Today's Range 5.820 - 7.850
    52wk Range 4.300 - 40.37
    Shares Outstanding 45,711,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Monday. ↗
    Via Chartmill

    Performance

    YTD
    -73.6%
    -73.6%
    1 Month
    -71.8%
    -71.8%
    3 Month
    -78.7%
    -78.7%
    6 Month
    -68.4%
    -68.4%
    1 Year
    +9.9%
    +9.9%

    More News

    Read More
    News headline image
    This Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    Capricor Therapeutics Inc (NASDAQ:CAPR) Q1 Results Show EPS Miss as Market Awaits August PDUFA Date ↗
    Via Chartmill
    Capricor Therapeutics Inc (NASDAQ:CAPR) Reports Q4 2025 Loss, Focus Remains on FDA Review for Deramiocel ↗
    Via Chartmill
    News headline image
    Capricor Therapeutics Eyes FDA Approval Path for Duchenne Cell Therapy ↗
    Via MarketBeat
    News headline image
    Capricor (CAPR) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Capricor Therapeutics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval ↗
    Via Stocktwits
    Topics Earnings
    News headline image
    CAPR Stock Heads For Best Week In Nearly A Month: CEO Says 'No Way' Deramiocel Gets Only Conditional Approval ↗
    Via Stocktwits
    Topics Earnings
    News headline image
    Capricor (CAPR) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Capricor Reports Wider Quarterly Loss Than Expected But All Eyes Are On Muscle Disease Therapy ↗
    Via Stocktwits
    News headline image
    Capricor Therapeutics’ DMD Treatment Study Shows Improvement In Key Heart Function Measures ↗
    Via Stocktwits
    News headline image
    CAPR Stock Surged 17% Today — What’s Fueling The Rally? ↗
    Via Stocktwits
    News headline image
    CAPR Stock In Spotlight As Investors Eye Next Week’s DMD Trial Data Showing Muscle And Cardiac Gains ↗
    Via Stocktwits
    News headline image
    Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government
    News headline image
    CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗
    Via Stocktwits
    News headline image
    CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗
    Via Stocktwits
    News headline image
    Here's Why This Biotechnology Skyrocketed by 439% in December ↗
    Via The Motley Fool
    News headline image
    On Friday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗
    Via Stocktwits

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 7.460
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 07/27/26 12:33 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 341.01M
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 341M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.